Swine flu vaccine programme confirmed.
|Article Type:||Brief article|
Wellness programs (Service introduction)
Swine influenza (Prevention)
|Publication:||Name: Community Practitioner Publisher: Ten Alps Publishing Audience: Academic Format: Magazine/Journal Subject: Health; Health care industry Copyright: COPYRIGHT 2009 Ten Alps Publishing ISSN: 1462-2815|
|Issue:||Date: Oct, 2009 Source Volume: 82 Source Issue: 10|
|Topic:||Event Code: 350 Product standards, safety, & recalls; 366 Services introduction Advertising Code: 57 New Products/Services Computer Subject: Company service introduction|
|Organization:||Government Agency: United Kingdom. Department of Health; United Kingdom. Department of Health Organization: British Medical Association|
|Geographic:||Geographic Scope: United Kingdom Geographic Code: 4EUUK United Kingdom|
The Department of Health (DH) and British Medical Association
General Practitioners Committee have confirmed a programme for the
delivery of the influenza A/H1N1v (swine flu) vaccine, but were awaiting
its licensing by the European Medicines Agency at time of going to
Only those identified as being in at-risk groups will receive the vaccine.
The DH will provide practices with a six-week extension on the delivery of non-swine flu childhood vaccinations, extending the deadline from the end of December to the middle of February.
Primary care trusts have been told that they must develop plans to identify people in these groups, including those who are not registered with a GP practice, and all NHS organisations must establish plans to vaccinate frontline staff.
The DH has stated that it will issue guidance on the supply and distribution mechanisms of the vaccine, and will detail how staff should collect data on the uptake of the vaccine.
Some health visitors and community staff nurses have begun to receive training in giving the swine flu vaccine.
One health visitor, who did not want to be named, stated: 'The plan was that we would obtain experience and confidence by helping school nurses to give the human papillo-mavirus vaccine and thereafter we should be prepared, if we are needed, for a mass immunisation programme. Our senior manager has told us that she has tried to minimise expectations for our involvement because so many primary healthcare teams are already understaffed, but I am not sure that she felt listened to.'
|Gale Copyright:||Copyright 2009 Gale, Cengage Learning. All rights reserved.|